Gilead Sciences (NASDAQ: GILD) has been a favorite among biotech investors due to its successful hepatitis C therapies; Harvoni and Sovaldi. However, the biopharmaceutical company is making headlines again with a new drug for gastric cancer; GS-5745. GS-5745 is advancing into Phase III testing in the third quarter, prompting RBC Capital analyst Michael Yee to reiterate an Outperform…
Businesses set long-term goals they strive to achieve and here is the optimal method for doing so. Listen to New England Patriots’ Quarterback Tom Brady and… 1) When Achieving Your Goals, Eliminate Distractions To not get distracted from achieving your goals created in the business plan, businesses have to remember to maintain focus and increase concentration. Distractions are where a business plan…
NEW YORK (AP) — Verizon is buying AOL for about $4.4 billion, advancing the telecom’s push in both mobile and advertising fields. The acquisition gives Verizon an entry into increasingly competitive online and mobile video. The New York company is the country’s largest wireless carrier as well as an Internet and TV provider — and…
When my co-founder and I started VenturePact, we had a ton of excitement and energy. We believed that we had a great solution to the tech talent crunch and were going to bring great changes to the industry. But then something unexpected happened. Have you ever gone for a hike through the woods and found…
A biotechnology company developing an unusual drug—derived from the venom of a sea anemone to treat autoimmune diseases such as psoriasis and multiple sclerosis—reported encouraging results from a phase 1 clinical trial. Seattle-based Kineta Inc. said it expects early next year to begin recruiting patients for the next stage of the drug’s development, a phase…
The Obama Administration’s hotly debated plan to reduce heat-trapping carbon dioxide from the nation’s power plants will save about 3,500 lives a year by cutting back on other types of pollution as well, a new independent study concludes. A study from Harvard and Syracuse University calculates the decline in heart attacks and lung disease when…
